<body><script type="text/javascript"> function setAttributeOnload(object, attribute, val) { if(window.addEventListener) { window.addEventListener('load', function(){ object[attribute] = val; }, false); } else { window.attachEvent('onload', function(){ object[attribute] = val; }); } } </script> <div id="navbar-iframe-container"></div> <script type="text/javascript" src="https://apis.google.com/js/platform.js"></script> <script type="text/javascript"> gapi.load("gapi.iframes:gapi.iframes.style.bubble", function() { if (gapi.iframes && gapi.iframes.getContext) { gapi.iframes.getContext().openChild({ url: 'https://www.blogger.com/navbar/5621345630369022014?origin\x3dhttps://cderwn.blogspot.com', where: document.getElementById("navbar-iframe-container"), id: "navbar-iframe" }); } }); </script>

Drug Evaluation & Research

CDERNEW-TEXT 9/13/2007


Friday, September 14, 2007

September 13, 2007

Approved Drug Products with Therapeutic Equivalence Evaluations Orange
Book http://www.fda.gov/cder/orange/default.htm

Fentora (fentanyl buccal tablet)
http://www.fda.gov/medwatch/safety/2007/safety07.htm#Fentora

- Cephalon
issues two Dear Healthcare Professional Letters to inform prescribers
and other healthcare providers of important safety information regarding
Fentora.

New and Generic Drug Approvals
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm

Amlodipine Besylate Tablets, Lek Pharma, Approval

Cefazolin Injection, USP and Dextrose Injection, USP in the Duplex
Container, B. Braun Medical, Labeling Revision

Cefuroxime Injection and Dextrose Injection in the Duplex Container, B.
Braun Medical, Labeling Revision

Colgate Total (sodium fluoride and triclosan dentifrice) Toothpaste,
Colgate-Palmolive, Formulation Revision

Griseofulvin Oral Suspension, Ivax Pharma, Approval

Humulin R (insulin [rDNA origin]) Human Injection, Eli Lilly, Labeling
Revision

Ibuprofen Tablets, Northstar Healthcare, Approval

Lamotrigine Tablets, Dr. Reddy's Labs, Tentative Approval

Lamotrigine Chewable Tablets, Dr. Reddy's Labs, Tentative Approval

Levaquin (levofloxacin) Tablets, Ortho-McNeil Pharma, Patient Population
Altered

Levaquin (levofloxacin) Injection and Levaquin (levofloxacin in
dextrose) Injection, Ortho-McNeil Pharma, Patient Population Altered

Levaquin (levofloxacin) Oral Solution, Ortho-McNeil Pharma, Patient
Population Altered

Motrin (ibuprofen) Tablets, McNeil Pediatrics, Labeling Revision

Motrin (ibuprofen) Suspension, McNeil Pediatrics, Labeling Revision

Pantoprazole Sodium Delayed Release Tablet, Sun Pharma, Approval

Septra and Septra DS (trimethoprim/sulfamethoxazole) Tablets, Monarch
Pharma, Labeling Revision

------------------------------------------------
To subscribe or to unsubscribe from CDERNEW-TEXT

http://list.nih.gov/archives/cdernew-text.html
------------------------------------------------

posted by Mags @ 9:36 AM,




0 Comments:

Post a Comment

<< Home